Compare DexCom, Inc. (DXCM) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? DexCom, Inc. trades at $89.11 (market cap $33.79B), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.64. The key difference: DexCom, Inc. is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| DXCM | EMLC | |
|---|---|---|
Market Cap | $33.79B | — |
Sector | Health | Fixed Income |
52-Week High | $89.53 | $26.59 |
52-Week Low | $54.84 | $24.83 |
Enterprise Value | $33.24B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $87.65, up 3.42% today and near its 52-week high, with a bullish technical signal from moving averages and strong fundamental performance. Revenue grew to $4.66B in 2025, with net income reaching $836.30M and a 20.12% net margin. Recent Q2 2026 earnings beat expectations with $0.70 EPS, and the company raised full-year guidance, reflecting robust demand for its continuous glucose monitoring systems.
The outlook remains positive given consistent earnings beats, margin expansion, and analyst consensus favoring a buy rating with a $88.65 price target. Key risks include competitive pressures in medical devices and potential regulatory scrutiny, but growth drivers like G7 adoption and international expansion support upside potential for investors.
EMLC trades at $25.655, up 0.14% with a bullish technical signal from moving averages and neutral oscillators. The stock shows consistent dividend distributions, with recent payouts of $0.14 in June 2026. Support and resistance cluster around $26, indicating a key price level. Financial ratios are not provided in the snapshot, limiting fundamental assessment.
Outlook hinges on emerging market debt dynamics and Federal Reserve policy, as noted in recent news. Risks include volatility from macroeconomic shifts and regional instability. The technical setup suggests near-term stability, but fundamental clarity is needed for long-term confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
